Dashboard
Manage Tickers

SYNHSyneos Health, Inc.

Nasdaq syneoshealth.com


$ 42.98 $ 0.01 (0.02 %)    

Wednesday, 27-Sep-2023 15:59:30 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 429.05 $ 0.73 (0.17 %)
DIA $ 384.69 $ -0.36 (-0.09 %)
SPY $ 506.91 $ 0.38 (0.08 %)
TLT $ 88.55 $ 0.14 (0.16 %)
GLD $ 215.23 $ 0.74 (0.35 %)
$ 42.98
$ 42.98
$ 0.00 x 0
$ 0.00 x 0
$ 42.98 - $ 42.98
$ 22.89 - $ 52.23
7,386,241
na
4.48B
$ 1.76
$ 62.97
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2023 06-30-2023 10-Q
2 05-10-2023 03-31-2023 10-Q
3 02-16-2023 12-31-2022 10-K
4 11-04-2022 09-30-2022 10-Q
5 08-01-2022 06-30-2022 10-Q
6 04-28-2022 03-31-2022 10-Q
7 02-16-2022 12-31-2021 10-K
8 11-02-2021 09-30-2021 10-Q
9 08-06-2021 06-30-2021 10-Q
10 04-29-2021 03-31-2021 10-Q
11 02-18-2021 12-31-2020 10-K
12 10-29-2020 09-30-2020 10-Q
13 08-06-2020 06-30-2020 10-Q
14 04-30-2020 03-31-2020 10-Q
15 02-19-2020 12-31-2019 10-K
16 10-31-2019 09-30-2019 10-Q
17 08-06-2019 06-30-2019 10-Q
18 05-09-2019 03-31-2019 10-Q
19 03-18-2019 12-31-2018 10-K
20 11-06-2018 09-30-2018 10-Q
21 08-02-2018 06-30-2018 10-Q
22 05-09-2018 03-31-2018 10-Q
23 02-28-2018 12-31-2017 10-K
24 11-09-2017 09-30-2017 10-Q
25 07-27-2017 06-30-2017 10-Q
26 05-10-2017 03-31-2017 10-Q
27 02-28-2017 12-31-2016 10-K
28 10-31-2016 09-30-2016 10-Q
29 07-28-2016 06-30-2016 10-Q
30 05-02-2016 03-31-2016 10-Q
31 02-25-2016 12-31-2015 10-K
32 10-29-2015 09-30-2015 10-Q
33 07-30-2015 06-30-2015 10-Q
34 04-27-2015 03-31-2015 10-Q
35 02-24-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

syneos-health-tapped-pra-health-sciences-colin-shannon-as-the-ceo-succeeding-michelle-keefe
Syneos Health Tapped PRA Health Sciences' ...
10/03/2023 12:18:00

On October 3, 2023, Syneos Health, Inc. (the “Company”) publicly announced that Colin Shannon has been appointed Chief Executiv...

Core News & Articles
Civitas Resources Set To Join S&P MidCap 400
09/26/2023 21:44:03

Core News & Articles
Syneos Health and Oracle to Expand Relatio...
09/12/2023 11:35:59

Syneos Health® (NASDAQ:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic ...

syneos-health-signs-agreement-with-aotearoa-clinical-trials-further-expanding-catalyst-site-program-in-new-zealand
Syneos Health Signs Agreement With Aotearo...
08/10/2023 14:53:44

Syneos Health® (NASDAQ:SYNH) a leading fully integrated biopharmaceutical  solutions organization, today announced that it has ...

syneos-health-stockholders-approve-agreement-with-private-investment-consortium
Syneos Health Stockholders Approve Agreeme...
08/02/2023 12:48:14

Syneos Health, Inc. (NASDAQ:SYNH) ("Syneos Health" or the "Company"), a leading fully integrated biopharmaceuti...

click-therapeutics-launches-additional-randomized-clinical-study-in-migraine-conducted-in-partnership-with-syneos-health
Click Therapeutics Launches Additional Ran...
08/02/2023 12:17:22

● The study marks Click's second active randomized clinical trial testing digital interventions in migraine patients. ● Th...

Core News & Articles
FSD Pharma Says Arbitration Panel Finds Th...
07/17/2023 21:07:20

opgen-subsidiary-ares-genetics-maintains-patent-titled-genetic-resistance-prediction-against-antimicrobial-drugs-in-microorganism-using-structural-changes-in-the-genome-in-europe
OpGen Subsidiary Ares Genetics Maintains P...
06/26/2023 11:37:00

syneos-health-announces-collaboration-with-umotif-umotif-to-provide-ecoa-and-epro-services-for-syneos-and-companies-will-develop-and-deploy-an-exclusive-platform
Syneos Health Announces Collaboration With...
06/26/2023 11:35:49

fivephusion-collaborates-with-treehill-partners-and-syneos-health
FivepHusion Collaborates with Treehill Par...
05/26/2023 07:13:09

FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New ...

8-analysts-have-this-to-say-about-syneos-health
8 Analysts Have This to Say About Syneos H...
05/16/2023 21:02:18

syneos-health-target-price-raised-amid-71b-acquisition-news-analyst-provides-insight
Syneos Health Target Price Raised Amid $7....
05/16/2023 18:34:55

mizuho-maintains-neutral-on-syneos-health-raises-price-target-to-43
Mizuho Maintains Neutral on Syneos Health,...
05/16/2023 10:44:29

Mizuho analyst Ann Hynes maintains Syneos Health (NASDAQ:SYNH) with a Neutral and raises the price target from $38 to $43.

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
05/11/2023 15:00:42

baird-downgrades-syneos-health-to-neutral-announces-43-price-target
Baird Downgrades Syneos Health to Neutral,...
05/11/2023 09:54:58

Baird analyst Eric Coldwell downgrades Syneos Health (NASDAQ:SYNH) from Outperform to Neutral and announces $43 price target.

deutsche-bank-downgrades-syneos-health-to-hold-lowers-price-target-to-43
Deutsche Bank Downgrades Syneos Health to ...
05/11/2023 09:05:31

Deutsche Bank analyst Justin Bowers downgrades Syneos Health (NASDAQ:SYNH) from Buy to Hold and lowers the price target from...

barclays-upgrades-syneos-health-to-equal-weight-announces-43-price-target
Barclays Upgrades Syneos Health to Equal-W...
05/11/2023 08:55:37

Barclays analyst Luke Sergott upgrades Syneos Health (NASDAQ:SYNH) from Underweight to Equal-Weight and announces $43 price ...

earnings-scheduled-for-may-10-2023
Earnings Scheduled For May 10, 2023
05/10/2023 13:12:28

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on ...

syneos-to-be-acquired-by-private-investment-consortium-for-71b-q1-earnings-beat-expectations
Syneos To Be Acquired By Private Investmen...
05/10/2023 13:01:01

syneos-health-q1-earnings-insights
Syneos Health: Q1 Earnings Insights
05/10/2023 11:15:51

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION